BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mihai DP, Nitulescu GM, Ion GND, Ciotu CI, Chirita C, Negres S. Computational Drug Repurposing Algorithm Targeting TRPA1 Calcium Channel as a Potential Therapeutic Solution for Multiple Sclerosis. Pharmaceutics 2019;11:E446. [PMID: 31480671 DOI: 10.3390/pharmaceutics11090446] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Andrei C, Mihai DP, Zanfirescu A, Nitulescu GM, Negres S. In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity. Pharmaceutics 2022;14. [PMID: 36559057 DOI: 10.3390/pharmaceutics14122563] [Reference Citation Analysis]
2 Sun G, Dong D, Dong Z, Zhang Q, Fang H, Wang C, Zhang S, Wu S, Dong Y, Wan Y. Drug repositioning: A bibliometric analysis. Front Pharmacol 2022;13:974849. [DOI: 10.3389/fphar.2022.974849] [Reference Citation Analysis]
3 Lv B, Shen N, Cheng Z, Chen Y, Ding H, Yuan J, Zhao K, Zhang Y. Strategies for Biomaterial-Based Spinal Cord Injury Repair via the TLR4-NF-κB Signaling Pathway. Front Bioeng Biotechnol 2022;9:813169. [DOI: 10.3389/fbioe.2021.813169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yang X, Ling S, Zhou M, Deng H, Qi M, Liu X, Zhen C, Chen Y, Fan X, Wu Z, Ma F, Rong J, Di G, Jiang X. Inhibition of TRPA1 attenuates oxidative stress-induced damage after traumatic brain injury via the ERK/AKT signaling pathway. Neuroscience 2022. [DOI: 10.1016/j.neuroscience.2022.02.003] [Reference Citation Analysis]
5 Szabó K, Kemény Á, Balázs N, Khanfar E, Sándor Z, Boldizsár F, Gyulai R, Najbauer J, Pintér E, Berki T. Presence of TRPA1 Modifies CD4+/CD8+ T Lymphocyte Ratio and Activation. Pharmaceuticals (Basel) 2022;15:57. [PMID: 35056114 DOI: 10.3390/ph15010057] [Reference Citation Analysis]
6 Zanfirescu A, Nitulescu G, Mihai DP, Nitulescu GM. Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing. Pharmaceuticals (Basel) 2021;15:38. [PMID: 35056095 DOI: 10.3390/ph15010038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Nitulescu G, Nitulescu GM, Zanfirescu A, Mihai DP, Gradinaru D. Candidates for Repurposing as Anti-Virulence Agents Based on the Structural Profile Analysis of Microbial Collagenase Inhibitors. Pharmaceutics 2021;14:62. [PMID: 35056958 DOI: 10.3390/pharmaceutics14010062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sodhi RK, Singh R, Bansal Y, Bishnoi M, Parhar I, Kuhad A, Soga T. Intersections in Neuropsychiatric and Metabolic Disorders: Possible Role of TRPA1 Channels. Front Endocrinol (Lausanne) 2021;12:771575. [PMID: 34912298 DOI: 10.3389/fendo.2021.771575] [Reference Citation Analysis]
9 Mihai DP, Ungurianu A, Ciotu CI, Fischer MJM, Olaru OT, Nitulescu GM, Andrei C, Zbarcea CE, Zanfirescu A, Seremet OC, Chirita C, Negres S. Effects of Venlafaxine, Risperidone and Febuxostat on Cuprizone-Induced Demyelination, Behavioral Deficits and Oxidative Stress. Int J Mol Sci 2021;22:7183. [PMID: 34281235 DOI: 10.3390/ijms22137183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Startek JB, Milici A, Naert R, Segal A, Alpizar YA, Voets T, Talavera K. The Agonist Action of Alkylphenols on TRPA1 Relates to Their Effects on Membrane Lipid Order: Implications for TRPA1-Mediated Chemosensation. Int J Mol Sci 2021;22:3368. [PMID: 33806007 DOI: 10.3390/ijms22073368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ciotu CI, Fischer MJM. Novel Analgesics with Peripheral Targets. Neurotherapeutics 2020;17:784-825. [PMID: 33063247 DOI: 10.1007/s13311-020-00937-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Tian C, Li S, He L, Han X, Tang F, Huang R, Lin Z, Deng S, Xu J, Huang H, Zhao H, Li Z. Transient receptor potential ankyrin 1 contributes to the lysophosphatidylcholine-induced oxidative stress and cytotoxicity in OLN-93 oligodendrocyte. Cell Stress Chaperones 2020;25:955-68. [PMID: 32572784 DOI: 10.1007/s12192-020-01131-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Mihai DP, Trif C, Stancov G, Radulescu D, Nitulescu GM. Artificial Intelligence Algorithms for Discovering New Active Compounds Targeting TRPA1 Pain Receptors. AI 2020;1:276-85. [DOI: 10.3390/ai1020018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ritter C, Dalenogare DP, de Almeida AS, Pereira VL, Pereira GC, Fialho MFP, Lückemeyer DD, Antoniazzi CT, Kudsi SQ, Ferreira J, Oliveira SM, Trevisan G. Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation. Mol Neurobiol 2020;57:2420-35. [PMID: 32095993 DOI: 10.1007/s12035-020-01891-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
15 Liu J, Yang J, Hou Y, Zhu Z, He J, Zhao H, Ye X, Li D, Wu Z, Huang Z, Hao B, Yao K. Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase. Cancer Cell Int 2019;19:348. [PMID: 31889900 DOI: 10.1186/s12935-019-1069-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]